J&J weathers fallout from Red Cross suit

Just as we predicted--though, frankly, it wasn't a tough call--Johnson & Johnson has found itself in the midst of a PR nightmare over its trademark dust-up with the American Red Cross. Newspapers are even editorializing about it; the Cleveland Plain Dealer's editorial page juxtaposes big, bad corporate J&J and its lawyers against humanitarian, nurse, and Red Cross founder Clara Barton. By those lights, J&J might have sued Mother Teresa.

To its credit, J&J did know what it was getting into. On the day the story broke, the company's corp comm VP admitted he "appreciated how undeniably juicy the story would be." Friday, CEO Bill Weldon issued talking points to employees--which included a pledge to donate any damages won in the lawsuit to charity. Otherwise, the company is sticking to its guns. The suit is about "upholding the law" and preventing "dangerous precedent," the company's blog states. We'll have to wait and see which is more dangerous: the precedent or the lawsuit itself.

- here's the article from AdAge
- read the report from the Cleveland Plain Dealer

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

The new Community trial will first test Amgen's Otezla, Takeda's Takhzyro and UCB's zilucoplan in hospitalized patients.

Indivior faces a new lawsuit from RB, its former parent company, over a scheme to market opioid addiction therapy Suboxone Film.

A new FDA effort brings cancer drug labels to life in videotaped panels with experts, debuting its first episode on Seagen's MBC med Tukysa.